Tepha closes royalty rights buyout from Metabolix October 11, 2016 By Fink Densford Implantable medical device developer Tepha said today it completed a buy-out of its roylaty obligations with former licensor and parent company Metabolix. Get the rest of the story at our sister site, Medical Design & Outsourcing